SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-000759
Filing Date
2022-01-10
Accepted
2022-01-10 07:08:13
Documents
14
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlry-8k_20220110.htm   iXBRL 8-K 43078
2 EX-99.1 tlry-ex991_6.htm EX-99.1 1185862
3 GRAPHIC gia1rfp3jfcy000001.jpg GRAPHIC 48950
  Complete submission text file 0001564590-22-000759.txt   1466717

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlry-20220110.xsd EX-101.SCH 5677
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20220110_lab.xml EX-101.LAB 19335
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20220110_pre.xml EX-101.PRE 11480
8 EXTRACTED XBRL INSTANCE DOCUMENT tlry-8k_20220110_htm.xml XML 3547
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 22519659
SIC: 2833 Medicinal Chemicals & Botanical Products